• PMH13 ESTIMATING THE BENEFIT OF LONG-ACTING INJECTABLES FOR SCHIZOPHRENIA TREATMENT IN RWANDA USING A ONE-YEAR COST-CONSEQUENCE MODEL

    May 1, 2019, 00:00

  • PNS95 DEMOGRAPHIC CHARACTERISTICS OF PATIENTS RECEIVING PRIVATELY FINANCED HEALTH CARE SERVICES IN HUNGARIAN PUBLICLY FINANCED HOSPITALS

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Epidemiology Public Health

    May 1, 2019, 00:00

  • PMU103 THE DEVELOPMENT AND IMPLEMENTATION OF MOBILE APPLICATIONS FOR THE COLLECTION OF PATIENT EXPERIENCE DATA

    May 1, 2019, 00:00

  • PCV49 COST-EFFECTIVENESS OF ALIROCUMAB FOR PATIENTS WITH HYPERCHOLESTEROLEMIA AT HIGH CV RISK

    May 1, 2019, 00:00

  • PCN253 DECISION-MAKER PERSPECTIVES ON OUTCOMES STUDIED IN LEUKAEMIA CLINICAL TRIALS: THE RESPONSE EVALUATION IN LEUKAEMIA (REVALEU) STUDY PROTOCOL

    May 1, 2019, 00:00

  • PNS134 MEASUREMENT OF TURKISH HEALTH SYSTEM INDICATOR AMONG POPULATION HEALTHCARE SATISFACTION: CROSS SECTIONAL STUDY

    May 1, 2019, 00:00

  • PIH6 PREVALENCE OF ADVERSE EVENTS AMONG CHILDREN TAKING MULTIPLE VERSUS SINGLE ANTIPSYCHOTICS

    May 1, 2019, 00:00

  • Multiple Diseases - Organizational Practices

    May 1, 2019, 00:00

  • PNS35 IS NICE COST-EFFECTIVE?

    May 1, 2019, 00:00

  • PIH66 POLYCYSTIC OVARIAN SYNDROME (PCOS): A LITERATURE REVIEW OF THE POLYCYSTIC OVARY SYNDROME QUESTIONNAIRE (PCOSQ) FROM 2013-2018

    May 1, 2019, 00:00

  • PMD33 ECONOMIC BENEFITS OF POWERED AND TISSUE-SPECIFIC ENDOSCOPIC STAPLERS IN THE PATIENTS UNDERGOING VIDEO-ASSISTED THORACIC PULMONARY RESECTION

    May 1, 2019, 00:00

  • Copyright/Subscription

    May 1, 2019, 00:00

  • PIN56 EPIDEMIOLOGY OF HPV-RELATED CERVICAL LESIONS IN MID-ADULT WOMEN IN AFRICA

    May 1, 2019, 00:00

  • PIN102 ARE LIVER-RELATED MORTALITY RATES DECREASING AFTER HEPATITIS B VACCINATION? CHALLENGES AND OPPORTUNITIES IN ASSESSING THE IMPACT OF HBV VACCINATION ON MORTALITY BY LIVER DISEASES IN DEVELOPING COUNTRIES. AN ECOLOGICAL ANALYSIS OF COL ...

    May 1, 2019, 00:00

  • PCN291 ACUTE GRAFT VERSUS HOST DISEASE (GVHD), CHRONIC GVHD AND NON-RELAPSE MORTALITY (NRM) ASSOCIATED WITH MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT): A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PMS46 OPIOID USAGE AND PATIENT-REPORTED PAIN SCORES IN RHEUMATOID ARTHRITIS PATIENTS: A RETROSPECTIVE ANALYSIS OF A LARGE US ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • PNS55 COST-BENEFIT ANALYSIS OF THREE TYPES LOW TEMPERATURE STERILIZATION SYSTEM: ETHYLENE OXIDE VERSUS FORMALDEHYDE VERSUS PEROXIDE PLASMA IN ENDOSCOPE STERILIZATION

    May 1, 2019, 00:00

  • PMD22 COST-BENEFIT ANALYSIS OF BARIATRIC SURGERY FROM A PRIVATE AND PUBLIC THIRD-PARTY PAYER PERSPECTIVE IN CHILE

    May 1, 2019, 00:00

  • Multiple Diseases - Patient-Centered Research

    May 1, 2019, 00:00

  • PNS142 INITIAL DEVELOPMENT OF AN INSTRUMENT TO ASSESS THE EFFECTIVENESS OF ACADEMIC DETAILING VISITS

    May 1, 2019, 00:00

  • PCN310 REAL WORLD SURVIVAL OUTCOMES WITH MODIFIED DOSE SCHEDULE OF BORTEZOMIB, MELPHALAN AND PREDNISONE IN PREVIOUSLY UNTREATED TRANSPLANT INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA: A POPULATION BASED OBSERVATIONAL STUDY

    May 1, 2019, 00:00

  • PNS39 INFLUENCING FACTORS AND FORMULARY CONSEQUENCES OF BUDGET IMPACT THRESHOLDS AS PERCEIVED BY PAYERS

    May 1, 2019, 00:00

  • Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies

    May 1, 2019, 00:00

  • PND34 ECONOMIC BURDEN OF PROBABLE LENNOX-GASTAUT SYNDROME, PROBABLE DRAVET SYNDROME, AND OTHER REFRACTORY EPILEPSIES FOR UNITED STATES MEDICAID HEALTH PLANS

    May 1, 2019, 00:00

  • PIT15 COMPLICATIONS, HEALTH RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH HARDWARE REMOVAL WITHIN 1-YEAR AFTER OPEN REDUCTION INTERNAL FIXATION OF HUMERUS FRACTURES

    May 1, 2019, 00:00

  • PMD44 DISCRETE CHOICE PREFERENCES FOR PROSTHETIC INNOVATIONS IN PERSONS WITH UPPER LIMB LOSS

    May 1, 2019, 00:00

  • PDG15 IMPACT OF USING REAL-WORLD OUTCOMES DATA VERSUS CLINICAL EVIDENCE AND PUBLISHED PRICES IN VALUE ASSESSMENTS

    May 1, 2019, 00:00

  • PIH71 HEALTH UTILITIES IN PEDIATRIC CANCER PATIENTS AND SURVIVORS: EVIDENCE FROM META-ANALYSIS

    May 1, 2019, 00:00

  • PND45 PHARMACOLOGICAL AND NON-PHARMACOLOGICAL STRATEGIES USED BY COMMUNITY DWELLING ADULTS TO MANAGE MIGRAINE: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PMH49 FACILITY AND STATE-LEVEL FACTORS ASSOCIATED WITH TELEMENTAL HEALTH (TMH) ADOPTION AMONG MENTAL HEALTH FACILITIES IN THE UNITED STATES (US)

    May 1, 2019, 00:00

  • PMD32 MINIMALLY INVASIVE VS OPEN SPINAL FUSION SURGERY: CLINICAL AND ECONOMIC PERIOPERATIVE EVALUATION IN A HOSPITAL BILLING DATABASE USING MATCHED COHORTS

    May 1, 2019, 00:00

  • Injury Public Health

    May 1, 2019, 00:00

  • PDB41 TRENDS IN THE BURDEN OF OUT OF POCKET PAYMENTS IN DIABETES CARE: AN ANALYSIS OF THE MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2019, 00:00

  • PDG46 PREVALENCE AND PREDICTORS OF POTENTIALLY INAPPROPRIATE MEDICATION PRESCRIBING FOR ELDERLY PATIENTS: A POPULATION-BASED CROSS-SECTIONAL STUDY

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PNS159 A STUDY OF PUBLIC HEALTH INFRASTRUCTURE AND HEALTH MANPOWER OF SUB-CENTERS IN INDIA

    May 1, 2019, 00:00

  • PMD10 COST EFFECTIVENESS ANALYSIS OF CARDIAC RESYNCHRONIZATION THERAPY FOR HEART FAILURE FROM A PUBLIC THIRD-PARTY PAYER PERSPECTIVE IN CHILE

    May 1, 2019, 00:00

  • PIH17 DIRECT COSTS OF MATERNAL CARE WITH PREECLAMPSIA: STANDARD AND OBSERVED COSTS IN COLOMBIA

    May 1, 2019, 00:00

  • PCN312 THE ECONOMIC BURDEN OF MELANOMA PATIENTS IN CHINA

    May 1, 2019, 00:00

  • PIH11 EXAMINING CERVICAL CANCER SCREENING INTERVALS AMONG WOMEN WITH NEWLY DIAGNOSED CERVICAL CANCER

    May 1, 2019, 00:00

  • PIN10 COSTS ASSOCIATED WITH FOODBORNE DISEASES IN A POOR POPULATION INSURED IN THE DEPARTMENT OF BOLIVAR, COLOMBIA

    May 1, 2019, 00:00

  • PNS216 INCOME-ELASTICITY OF THE BODY MASS INDEX. RESULTS FROM A PERUVIAN HOUSEHOLD SURVEY

    May 1, 2019, 00:00

  • PNS61 UNMET MEDICAL NEED AND HEALTH DISPARITIES AMONG U.S. ADULTS

    May 1, 2019, 00:00

  • PIN96 DEVELOPMENT OF PATIENT-REPORTED OUTCOME (PRO) AND OBSERVER-REPORTED OUTCOME (OBSRO) MEASURES FOR ASSESSMENT OF SYMPTOM INTENSITY IN DENGUE ILLNESS

    May 1, 2019, 00:00

  • PDB84 LIVER BIOPSY - A BOTTLENECK TO NASH DIAGNOSIS

    May 1, 2019, 00:00

  • PCV61 COMPARING ISCHAEMIC HEART DISEASE MORTALITY BETWEEN EASTERN AND WESTERN EUROPEAN COUNTRIES

    May 1, 2019, 00:00

  • PMH50 AFFECTING THE OPIOID CRISIS THROUGH OBSERVATIONAL RESEARCH: INSIGHTS FOR PREVENTION

    May 1, 2019, 00:00

  • PDB32 BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN/METFORMIN EXTENDED-RELEASE TABLETS FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CHINA

    May 1, 2019, 00:00

  • PDG65 FACTORS IMPACTING THE LIFE CYCLE OF GENERIC PRESCRIPTIONS

    May 1, 2019, 00:00

  • PMU16 THE ESTIMATED ECONOMIC BURDEN OF CANCERS ATTRIBUTABLE TO SUBOPTIMAL DIET IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS147 A FRAMEWORK FOR VETTING "GOOD” OUTCOMES-BASED MEASURES IN ALTERNATIVE PAYMENT MODELS

    May 1, 2019, 00:00

  • NO Specific Disease - Health Technology Assessment

    May 1, 2019, 00:00

  • PIT13 IMPACT OF REOPERATIONS ON ONE-YEAR HEALTH CARE RESOURCE UTILIZATION AND COSTS AFTER INTRAMEDULLARY FIXATION OF PERTROCHANTERIC HIP FRACTURES

    May 1, 2019, 00:00

  • Individual's Health - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PMU38 ASSOCIATION OF PRESCRIPTION NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) WITH DEPRESSION AMONG ADULTS WITH INFLAMMATORY CHRONIC CONDITIONS IN THE UNITED STATES

    May 1, 2019, 00:00

  • PND35 ESTIMATE OF THE IMPACT AND COSTS OF MIGRAINE FROM AN HEALTH PLAN IN BRAZIL: REAL WORLD SCENARIO STUDY

    May 1, 2019, 00:00

  • PMH63 A REAL WORLD ASSESSMENT OF OUTCOMES IN SCHIZOPHRENIA PATIENTS ACCORDING TO TREATMENT RESPONSE

    May 1, 2019, 00:00

  • PIH26 HEALTHCARE RESOURCE UTILIZATION AND DIRECT MEDICAL COSTS ASSOCIATED WITH GENITAL WARTS IN DOMINICAN REPUBLIC

    May 1, 2019, 00:00

  • PMU72 EVALUATION OF MEDICATION-RELATED PROBLEMS AMONG RURAL COMMUNITY-DWELLING PATIENTS RECEIVING MEDICATION THERAPY MANAGEMENT FOR DIABETES AND/OR HYPERTENSION

    May 1, 2019, 00:00

  • PMU10 MACHINE LEARNING APPROACHES TO FEATURE EXTRACTION WHEN PREDICTING MEDICATION COMPLIANCE AND PERSISTENCY

    May 1, 2019, 00:00

  • PNS93 IMPACT RESEARCH OF MEDICINE MARKUPS POLICY REFORM ON ECONOMIC OPERATION OF PUBLIC HOSPITALS IN A DISTRICT OF SHANGHAI

    May 1, 2019, 00:00

  • PNS234 HEALTH BEHAVIOR AND SUBJECTIVE HEALTH STATUS OF FOREIGN STUDENTS IN HUNGARY

    May 1, 2019, 00:00

  • PNS121 COMPARISON BETWEEN PRICING AND VOLUME CHANGE CONTRIBUTION TO THE TOTAL EXPENDITURE INCREASE: EXAMINING TRENDS AMONG VARIOUS TYPES OF MEDICAL SERVICE ITEMS

    May 1, 2019, 00:00

  • PDB51 COST ANALYSIS COMPARING TWO HUMAN ALLOGRAFTS IN HEALING DIABETIC FOOT ULCERS OVER A 16 WEEK PERIOD

    May 1, 2019, 00:00

  • Medical Devices - Economic Evaluation

    May 1, 2019, 00:00

  • Drugs Generics - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PND81 PATIENT GLOBAL IMPRESSION OF CHANGE RELATED TO IMPROVEMENT IN MOST BOTHERSOME SYMPTOM FOLLOWING TREATMENT WITH EPTINEZUMAB

    May 1, 2019, 00:00

  • PMU94 QUANTIFYING THE HEALTH IMPACT AND RETURN ON INVESTMENT OF A HOME MEAL DELIVERY SERVICE USING SIMULATION MODELING

    May 1, 2019, 00:00

  • PCV70 AMBULATORY BLOOD PRESSURE MONITORING IN THE DIAGNOSIS AND MANAGEMENT OF ARTERIAL HYPERTENSION IN CURRENT MEDICAL PRACTICE IN ALGERIA: MAPA DZ STUDY - FINAL ANALYSIS

    May 1, 2019, 00:00

  • PND30 ECONOMIC EVALUATION OF ABOBOTULINUM TOXIN A VS ONABOTULINUM TOXIN A IN REAL-LIFE CLINICAL MANAGEMENT OF CERVICAL DYSTONIA

    May 1, 2019, 00:00

  • PMS29 COST-EFFECTIVENESS ANALYSIS OF CURRENT TREATMENT GUIDELINES FOR WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS IN THE US – A DISCRETE-EVENT SIMULATION MODEL

    May 1, 2019, 00:00

  • PDG14 TRENDS IN UTILIZATION, SPENDING, AND PRICES OF OPIOID MEDICATIONS IN THE US MEDICAID PROGRAMS 1991 - 2017

    May 1, 2019, 00:00

  • PND37 COST-EFFECTIVENESS OF MIROGABALIN FOR THE TREATMENT OF POST-HERPETIC NEURALGIA IN TAIWAN

    May 1, 2019, 00:00

  • PND24 CHARACTERISTICS AND OUTCOMES OF HOSPITALIZED PEDIATRIC MULTIPLE SCLEROSIS PATIENTS

    May 1, 2019, 00:00

  • PNS174 INFLUENCING ICER: A REVIEW OF MANUFACTURER INVOLVEMENT IN ICER ASSESSMENTS

    May 1, 2019, 00:00

  • PCV56 COST- EFFECTIVENSS ANALYSIS OF COMBINING TRANDITIONAL CHINESE MEDICINE IN THE TREATMENT OF HYPERTENSION

    May 1, 2019, 00:00

  • PNS238 DEVELOPMENT OF A PATIENT-FRIENDLY TRAINING ON HEALTH ECONOMICS AND VALUE ASSESSMENT

    May 1, 2019, 00:00

  • PCN287 ADJUVANT ANDROGEN THERAPY UTILIZATION AND ASSOCIATED OUTCOMES IN MEDICARE-ENROLLED ELDERLY PROSTATE CANCER SURVIVORS

    May 1, 2019, 00:00

  • PIT9 EXAMINING THE REAL-WORLD HEALTHCARE COSTS OF TREATING CHRONIC WOUNDS

    May 1, 2019, 00:00

  • PND6 PARKINSON'S DISEASE PROGRESSION: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2019, 00:00

  • PMD19 ICD THERAPY FOR SUDDEN CARDIAC ARREST PREVENTION IS COST-EFFECTIVE IN THE 1.5 PREVENTION POPULATION IN BRAZIL

    May 1, 2019, 00:00

  • PDG26 BUDGET IMPACT ANALYSIS OF TOFACITINIB IN ADULT RHEUMATOID ARTHRITIS PATIENTS IN IRAQ

    May 1, 2019, 00:00

  • PIH14 IMPROVING DEMENTIA ECONOMICS THROUGH EARLIER COST-EFECTIVE ASSESSMENT

    May 1, 2019, 00:00

  • PMU50 COMPARING UTILIZATION, COST AND QUALITY IN DUAL ELIGIBLE MEDICARE ADVANTAGE AND FEE-FOR-SERVICE MEDICARE BENEFICIARIES

    May 1, 2019, 00:00

  • PCN309 REAL-WORLD CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA IN NORTH AMERICA AND EUROPE

    May 1, 2019, 00:00

  • PNS101 YOU REAP WHAT YOU SOW; EUNETHTA COMING TO FRUITION

    May 1, 2019, 00:00

  • PDG83 ATTITUDES AND INTENTION OF PHARMD STUDENTS TO USE STIMULANTS FOR ENHANCING ACADEMIC PERFORMANCE

    May 1, 2019, 00:00

  • PDG47 PRESCRIPTION PATTERNS AND INDICATIONS OF FLUOROQUINOLONES IN A GROUP OF AMBULATORY PATIENTS IN COLOMBIA, 2018

    May 1, 2019, 00:00

  • PDG45 ENOXAPARIN AND LIVER INJURY: SIGNAL DETECTION USING DATA FROM FDA ADVERSE EVENT REPORTING SYSTEM (FEARS)

    May 1, 2019, 00:00

  • PNS125 THE POLICY EFFECT OF MEDICAID EXPANSION ON POVERTY DISPARITY IN HEALTH INSURANCE COVERAGE

    May 1, 2019, 00:00

  • PMD41 ECONOMIC IMPACT OF NOVEL DIGITAL THERAPEUTICS IN DIABETES, DYSLIPIDEMIA, AND HYPERTENSION

    May 1, 2019, 00:00

  • PNS228 HEOR AND RWE SOURCING AND PROCUREMENT CHALLENGES AND OPPORTUNITIES: A BENCHMARKING SURVEY

    May 1, 2019, 00:00

  • PDG74 DRUG UTILIZATION OF PATIENTS WITH RESPIRATORY DISEASE AT COMMUNITY PHARMACIES IN CHINA: AN ANALYSIS OF CHEMICAL DRUGS (2014-2017)

    May 1, 2019, 00:00

  • PCV28 THE OUT-OF-POCKET BURDEN OF AMBULATORY BLOOD PRESSURE MONITORING: A UNITED STATES PERSPECTIVE IN THE COMMERCIAL INSURANCE MARKETPLACE

    May 1, 2019, 00:00

  • PNS3 RETHINKING THE IMPACT OF FORMULARY CHANGES ON PATIENT HEALTH OUTCOMES

    May 1, 2019, 00:00

  • PDG58 CLOSING THE MEDICARE PART D COVERAGE GAP: TRENDS IN DRUG UTILIZATION AND EXPENDITURES, 2008- 2015

    May 1, 2019, 00:00

  • PDB34 TRANSLATING THE REDUCTION OF GLYCATED HEMOGLOBIN INTO ECONOMIC AND CLINICAL CONSEQUENCES OF PATIENTS WITH HIGH CARDIOVASCULAR RISK. AN INCIDENCE MODEL FOR CHILEAN POPULATION WITH TYPE 2 DIABETES

    May 1, 2019, 00:00

  • PNS71 HAEMOVIGILANCE AND ADVERSE REACTIONS FOLLOWING BLOOD TRANSFUSIONS: A CROSS SECTIONAL STUDY IN A DEVELOPING COUNTRY.

    May 1, 2019, 00:00

  • PDG2 EFFICACY OF PIOGLITAZONE IN IMPROVING LIVER HISTOLOGY SCORES OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC-REVIEW AND META-ANALYSIS

    May 1, 2019, 00:00

  • PDB88 THE IMPACT OF PHARMACIST-DELIVERED MEDICATION THERAPY MANAGEMENT (MTM) ON OUTCOMES FOR PATIENTS WITH DIABETES: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PNS132 VALUE-BASED CONTRACTS - WHEN AND HOW CAN THEY ACTUALLY WORK?

    May 1, 2019, 00:00

  • PIN91 EFFICACY AND COST OF DAA THERAPY COMPARED WITH CLASSIC IFN THERAPY AMONG HCV PATIENTS IN CHINA: A REAL-WORLD STUDY

    May 1, 2019, 00:00

  • PND10 SYSTEMATIC LITERATURE REVIEW OF OUTCOMES ASSOCIATED WITH SINGLE AND DUAL STENT-ASSISTED COIL EMBOLIZATION IN WIDE-NECKED BIFURCATION ANEURYSMS

    May 1, 2019, 00:00

  • PCV34 ANNUAL HEALTH INSURANCE TREATMENT COST OF PHLEBITIS AND THROMBOPHLEBITIS: A NATIONWIDE, REAL-WORLD COST OF ILLNESS STUDY

    May 1, 2019, 00:00

  • PNS182 REAL-WORLD EVIDENCE ON THE RISE: EVALUATING THE USE OF REAL-WORLD EVIDENCE IN ICER ASSESSMENTS OF COMPARATIVE CLINICAL EFFECTIVENESS

    May 1, 2019, 00:00

  • PDB45 EVALUATING THE SHORT-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA

    May 1, 2019, 00:00

  • PMH44 ASSESSMENT OF ADHERENCE TO ADHD TREATMENT GUIDELINES AND IMPACT ON HEALTH RESOURCE UTILIZATION

    May 1, 2019, 00:00

  • PDG4 THE IMPACT OF ANTIBIOTIC TREATMENT TIME AND CLASS OF ANTIBIOTIC FOR ACUTE OTITIS MEDIA INFECTIONS ON THE RISK OF REVISITS

    May 1, 2019, 00:00

  • PCN279 IMPACT OF DEPRESSION AND ANXIETY ON ADHERENCE TO ADJUVANT ENDOCRINE TREATMENTS IN ELDERLY BREAST CANCER SURVIVORS

    May 1, 2019, 00:00

  • PGI17 COMORBID MENTAL HEALTH DISORDERS AND PATIENT-REPORTED PAIN SCORES IN IRRITABLE BOWEL SYNDROME PATIENTS: A RETROSPECTIVE ANALYSIS OF A LARGE US ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • PND20 COST-UTILITY OF CANNABIDIOL IN ADDITION TO BACKGROUND THERAPY VERSUS BACKGROUND THERAPY ALONE IN LENNOX-GASTAUT SYNDROME

    May 1, 2019, 00:00

  • PNS192 MULTI-COMPARATOR INCREMENTAL COST EFFECTIVENESS: A NOVEL APPROACH TO ASSESS THE COST-EFFECTIVENESS OF HEALTHCARE INTERVENTIONS

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Health Technology Assessment

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Real World Data Information Systems

    May 1, 2019, 00:00

  • PCV55 TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND COSTS OF CARE AMONG PATIENTS WITH NEWLY DIAGNOSED SYSTOLIC AND DIASTOLIC HEART FAILURE IN A US REAL-WORLD SETTING

    May 1, 2019, 00:00

  • Infectious Diseases - Clinical Outcomes

    May 1, 2019, 00:00

  • PMD7 FEMUR FRACTURES BY ANATOMY- RATES AND COSTS IN A HOSPITAL BILLING DATABASE

    May 1, 2019, 00:00

  • PCN255 AN ENHANCED APPROACH FOR ESTIMATING MEAN SURVIVAL TIME BASED ON FINITE MIXTURE MODELS: REDUCING UNCERTAINTY IN COST EFFECTIVENESS ANALYSIS

    May 1, 2019, 00:00

  • Gastrointestinal Disorders - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • Personalized Precision Medicine - Patient-Centered Research

    May 1, 2019, 00:00

  • PGI9 SURGERY-RELATED COSTS AVERTED BY THE USE OF BIOLOGIC DRUGS FOR THE TREATMENT OF CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE CALCULATED THROUGH A MATHEMATICAL MODEL

    May 1, 2019, 00:00

  • PMH52 ARE PHYSICIANS COMPLYING WITH AAP-2011 TREATMENT GUIDELINES FOR ADHD? A COMPARATIVE ANALYSIS OF SPECIALIST VS. NONSPECIALIST PRESCRIBING AND USE OF PSYCHOTHERAPY IN CHILDREN

    May 1, 2019, 00:00

  • PNS69 FACTORS ASSOCIATED WITH INITIATION OF E-CIGARETTE AMONG MIDDLE SCHOOL VS. HIGH SCHOOL CHILDREN

    May 1, 2019, 00:00

  • PIH54 UNMET NEEDS IN THE DIAGNOSIS AND MANAGEMENT OF WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER IN THE REAL WORLD

    May 1, 2019, 00:00

  • PNS233 A NEWLY DEVELOPED POWER PROCEDURE FOR SAMPLE SIZE PLANNING IN COA VALIDATION STUDIES

    May 1, 2019, 00:00

  • PNS65 DESCRIPTIVE EPIDEMIOLOGY OF SMOKING STATUS IN A REAL WORLD SAMPLE OF ADULTS IN THE UNITED STATES: 2010 - 2017

    May 1, 2019, 00:00

  • PCV106 ADHERENCE TO SELF-CARE RECOMMENDATIONS AND ASSOCIATED FACTORS AMONG ADULT HEART FAILURE PATIENTS AT GONDAR UNIVERSITY REFERRAL HOSPITAL, NORTHWEST ETHIOPIA

    May 1, 2019, 00:00

  • PMH9 COST-EFFECTIVENESS OF WEB-BASED DEPRESSION PROGRAMS FOR ADOLESCENTS

    May 1, 2019, 00:00

  • Drugs Generics - Health Technology Assessment

    May 1, 2019, 00:00

  • PNS157 IDENTIFICATION AND COST OF DIAGNOSTIC TESTS FOR INFECTION IN DIABETIC FOOT ULCERS, PRESSURE ULCERS, AND VENOUS LEG ULCERS

    May 1, 2019, 00:00

  • PDB24 COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN CHINA

    May 1, 2019, 00:00

  • Early Assessment of Proof-of-Problem to Guide Health Innovation

    May 1, 2019, 00:00

  • PCN272 HUMANISTIC BURDEN OF BREAST, PROSTATE AND COLORECTAL CANCER IN JAPAN AND CHINA: A POPULATION BASED NHWS SURVEY

    May 1, 2019, 00:00

  • PCV89 ANALYSIS OF THE LIST OF MEDICINES FOR TREATMENT OF HYPERTENSION IN PREGNANCY IN UKRAINE

    May 1, 2019, 00:00

  • PMS50 OPIOID USE, HEALTHCARE EXPENDITURES, AND PAIN SEVERITY IN OSTEOARTHRITIS PATIENTS USING PATIENT REPORTED PAIN SCORES TO ASSESS PAIN SEVERITY

    May 1, 2019, 00:00

  • PMS45 OPIOID USAGE AND PATIENT-REPORTED PAIN SCORES IN OSTEOARTHRITIS PATIENTS: A RETROSPECTIVE ANALYSIS OF A LARGE US ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • PMS32 VOLUME AND CHARACTERISTICS OF SPINAL DEFORMITY SURGICAL PATIENTS

    May 1, 2019, 00:00

  • PNS144 EFFECT OF FACILITY OWNERSHIP STRUCTURE ON TIME SPEND BY PHYSICIANS WITH PATIENTS

    May 1, 2019, 00:00

  • PIN51 HEALTHCARE RESOURCE UTILIZATION OF STAGE 3 STAGE 4 PRESSURE ULCER (PU) AND DIABETIC FOOT ULCER (DFU) PATIENTS TREATED EARLY WITH CLOSTRIDIAL COLLAGENASE OINTMENT (CCO) - A PAYER’S PERSPECTIVE

    May 1, 2019, 00:00

  • PMU89 APPLIED COMPARISON OF CARDINALITY MATCHING VERSUS PROPENSITY SCORE MATCHING FOR CAUSAL INFERENCE IN OBSERVATIONAL MEDICAL DEVICE RESEARCH: MINIMALLY-INVASIVE VERSUS OPEN THORACIC SEGMENTECTOMY

    May 1, 2019, 00:00

  • PCN244 UNBIASED TREATMENT EFFICACY DETECTION METHODS WHEN USING PATIENT REPORTED OUTCOMES IN SURVIVAL-DEPENDENT DROP-OUT

    May 1, 2019, 00:00

  • PIT19 MORTALITY AND ACUTE BURDEN OF BURN INJURY IN A MEDICAL CENTER IN TAIWAN

    May 1, 2019, 00:00

  • PIN25 IMPACT OF ANTIBIOTIC RESISTANCE ON TREATMENT OF PNEUMOCOCCAL DISEASE IN ETHIOPIA: AN AGENT-BASED MODELING SIMULATION

    May 1, 2019, 00:00

  • PMU27 1-YEAR POSTTRANSPLANT DIRECT NON-MEDICAL AND INDIRECT COSTS FOR RECIPIENTS AND CAREGIVERS IN THAILAND: A SURVEY FROM 5 TRANSPLANT CENTERS

    May 1, 2019, 00:00

  • PIN72 NONOCCUPATIONAL HIV POST-EXPOSURE PROPHYLAXIS IN NIGERIA: AN OVERVIEW OF RESEARCH STUDIES AND IMPLICATIONS FOR POLICY AND PRACTICE

    May 1, 2019, 00:00

  • PND78 PATIENT REPORTED OUTCOMES TOOLS AND SHARED DECISION-MAKING IN PEDIATRIC EPILEPSY POPULATION AND THEIR CAREGIVERS: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PNS194 COMPARISON OF SIMULATED CLINICIAN RANKINGS WITH SEMI-AUTOMATED AND AUTOMATED ALGORITHMS FOR VARIABLE SELECTION WHEN CONDUCTING ANCHORED MATCHING-ADJUSTED INDIRECT COMPARISONS

    May 1, 2019, 00:00

  • PND88 QUANTITATIVE RESEARCH IN PSYCHIATRY: CLINICAL UTILITY OF EXTENDED- AND IMMEDIATE-RELEASE FORMULATIONS OF AMANTADINE FOR DRUG-INDUCED EXTRAPYRAMIDAL REACTIONS

    May 1, 2019, 00:00

  • Infectious Diseases - Methodological Statistical Research

    May 1, 2019, 00:00

  • PNS149 THE MEDICAL AND SOCIAL MODELS OF DISABILITY.

    May 1, 2019, 00:00

  • PNS237 TIME TRADE-OFF TARIFFS BASED ON SF-12 QUESTIONNAIRE

    May 1, 2019, 00:00

  • PDG81 EVALUATION OF PROGESTERONE (17-ALPHA HYDROXYPROGESTERONE CAPROATE) UTILIZATION AND ADHERENCE IN WOMEN WITH A HIGH-RISK PREGNANCY

    May 1, 2019, 00:00

  • PDB115 IMPACTS OF HYPOPARATHYROIDISM ON PATIENT WORK PRODUCTIVITY AND OUT-OF-POCKET COSTS

    May 1, 2019, 00:00

  • PND73 DIFFERENTIATION OF EPISODIC MIGRAINE AND CHRONIC MIGRAINE USING A MACHINE LEARNING TECHNIQUE

    May 1, 2019, 00:00

  • PMD14 COST-EFFECTIVENESS OF SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY (SNPWT) VS TRADITIONAL NPWT FOR THE TREATMENT OF LOWER EXTREMITY ULCERS

    May 1, 2019, 00:00

  • PMS25 CHARACTERISTICS AND MONETARY COMPENSATION OF CAREGIVERS FOR PATIENTS WITH RHEUMATIC CONDITIONS

    May 1, 2019, 00:00

  • PDG60 DID CITIZEN PETITIONS PROLONG THE NUMBER OF APPROVAL DAYS OF GENERIC DRUGS?

    May 1, 2019, 00:00

  • PMU60 DEVELOPMENT OF A MEASURE OF PRESCRIBER SATISFACTION WITH ACADEMIC DETAILING

    May 1, 2019, 00:00

  • Neurological Disorders - Clinical Outcomes

    May 1, 2019, 00:00

  • PMU95 BCBSLA APPROACH USING NATURAL LANGUAGE PROCESSING (NLP) AND MACHINE LEARNING TO PREDICT THE RISK OF HOSPITALIZATIONS

    May 1, 2019, 00:00

  • PMU108 EFFECT OF TREATMENT PREFERENCE IN RANDOMIZED CONTROLLED TRIALS: SYSTEMATIC REVIEW OF LITERATURE AND META-ANALYSIS

    May 1, 2019, 00:00

  • PCV65 REAL-WORLD CHARACTERISTICS AND READMISSIONS AMONG PATIENTS UNDERGOING ABLATION FOR VENTRICULAR TACHYCARDIA: A RETROSPECTIVE DATABASE ANALYSIS OF COMMERCIALLY INSURED PATIENTS IN THE UNITED STATES

    May 1, 2019, 00:00

  • PMU25 RISK FACTORS FOR CVD ARE ASSOCIATED WITH INCREASED HEALTH CARE EXPENDITURES FOR PERSONS WITH SERIOUS MENTAL ILLNESS

    May 1, 2019, 00:00

  • PIH67 WHAT ELSE CAN COW MILK PROTEIN BE RESPONSIBLE FOR? – BEHAVIOURAL PROBLEMS IN CHILDREN WITH COW MILK PROTEIN ALLERGY

    May 1, 2019, 00:00

  • Infectious Diseases - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PIN70 ASSOCIATION BETWEEN INFLUENZA VACCINE EFFECTIVENESS AND HEALTHCARE UTILIZATIONS AMONG US ELDERLY POPULATION

    May 1, 2019, 00:00

  • PCV36 HEALTHCARE EXPENDITURES IN PATIENTS RECEIVING PHARMACOTHERAPY WITH APIXABAN OR WARFARIN FOR VENOUS THROMBOEMBOLISM (VTE): A COMPARATIVE STUDY

    May 1, 2019, 00:00

  • PDB49 COST OFFSET MODEL USING MONTE-CARLO SIMULATION SHOWED REDUCED EMERGENCY MEDICAL PER-EVENT COSTS FOR NASAL GLUCAGON VERSUS INJECTABLE GLUCAGON

    May 1, 2019, 00:00

  • PIN53 PREDICTORS OF HUMAN PAPILLOMAVIRUS (HPV) VACCINE SERIES ADHERENCE AMONG CHILDREN, ADOLESCENTS, AND YOUNG ADULTS IN THE UNITED STATES DURING 2006-2016

    May 1, 2019, 00:00

  • PMD21 COST BENEFIT ANALYSIS FOR CENTRIFUGAL VERSUS MEMBRANE-BASED THERAPEUTIC PLASMA EXCHANGE

    May 1, 2019, 00:00

  • PNS47 ASSESSMENT OF RESIDENTS' WILLINGNESS TO PAY FOR PHARMACEUTICAL CARE PROVIDED BY LICENSED PHARMACIST IN COMMUNITY PHARMACY IN SICHUAN PROVINCE OF CHINA

    May 1, 2019, 00:00

  • PIN80 PSYCHOMETRICS OF AN INSTRUMENT TO MEASURE PHARMACIST-PROVIDER COLLABORATION FOR PHARMACISTS IN HIV PATIENT CARE IN AMBULATORY SETTINGS

    May 1, 2019, 00:00

  • PCV3 THROMBOPROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ACUTE MEDICALLY ILL PATIENTS: A NETWORK META-ANALYSIS

    May 1, 2019, 00:00

  • PND82 IMPACT OF EPTINEZUMAB ON THE HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF PATIENTS WITH EPISODIC OR CHRONIC MIGRAINE: SF-36 ANALYSIS BY MONTHS 1 AND 3 ACROSS THE SPECTRUM OF MIGRAINE

    May 1, 2019, 00:00

  • PNS112 MANAGEMENT OF SPECIALTY DRUGS, SPECIALTY PHARMACIES, AND BIOSIMILARS IN THE UNITED STATES

    May 1, 2019, 00:00

  • PMU82 EFFECT OF CARBAPENEM RESISTANCE ON TOTAL HOSPITALIZATION COSTS AMONG INPATIENTS WITH PSEUDOMONAS AERUGINOSA: A MULTICENTER STUDY IN CHINA

    May 1, 2019, 00:00

  • PMU77 CELL AND GENE THERAPIES ARE ASSOCIATED WITH SUBSTANTIALLY LARGER QUALITY-ADJUSTED LIFE YEAR GAINS THAN CONVENTIONAL DRUGS AND BIOLOGICS

    May 1, 2019, 00:00

  • PIH5 DEVELOPMENT OF THE SIDE EFFECTS OF PEANUT ORAL IMMUNOTHERAPY DIARY (SEPOD)

    May 1, 2019, 00:00

  • PNS73 SEVERE ATOPIC DERMATITIS IN SPAIN: POPULATION-BASED EPIDEMIOLOGICAL STUDY

    May 1, 2019, 00:00

  • NO Specific Disease - Epidemiology Public Health

    May 1, 2019, 00:00

  • PNS225 A UNIFIED ANALYSIS AND MODELING FRAMEWORK FOR THE DESIGN OF OUTCOMES-BASED RISK-SHARING AGREEMENTS

    May 1, 2019, 00:00

  • PIN33 COST-EFFECTIVENESS ANALYSIS OF EFINACONAZOLE FOR THE TREATMENT OF MILD TO MODERATE TOENAIL ONYCHOMYCOSIS IN CANADA

    May 1, 2019, 00:00

  • PMD38 MUTUAL UNDERSTANDING BETWEEN SICKLE CELL DISEASE PATIENTS THAT REQUIRE BLOOD TRANSFUSION AND THEIR TREATING PHYSICIANS CONCERNING DRIVERS OF QUALITY OF LIFE

    May 1, 2019, 00:00

  • PDB70 PREVALENCE OF PERIPHERAL NEUROPATHY AND ASSOCIATED PAIN IN PATIENTS WITH DIABETES MELLITUS

    May 1, 2019, 00:00

  • Infectious Diseases - Economic Evaluation

    May 1, 2019, 00:00

  • Association Between Patient Experience With Patient-Reported Outcome Measurements and Overall Satisfaction With Care in Neurology

    May 1, 2019, 00:00

  • PIT22 UNDERSTANDING PATIENT JOURNEY IN TERMS OF HEALTHCARE RESOURCE UTILIZATION (HCRU) AND COST OF CARE AMONG PATIENTS WITH THERMAL BURNS AND AUTOGRAFT IN A LARGE MANAGED CARE POPULATION

    May 1, 2019, 00:00

  • PND76 ROLE OF MESSAGE FRAMING AND INVOLVEMENT ON INTENTION TO ENGAGE IN PREVENTIVE BEHAVIORS FOR COGNITIVE HEALTH MAINTENANCE

    May 1, 2019, 00:00

  • R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment

    May 1, 2019, 00:00

  • PIH73 DEVELOPMENT OF ILLUSTRATIONS TO FACILITATE CONCEPT ELICITATION INTERVIEWS WITH PEDIATRIC PARTICIPANTS

    May 1, 2019, 00:00

  • PNS153 THE PROVISION OF GATE-KEEPING PRACTICE TO MITIGATE THE ADVERSE EFFECTS OF LONG-TERM UNEMPLOYMENT DURING ECONOMIC CRISIS

    May 1, 2019, 00:00

  • PNS12 WHY ADVANCING DATA VISUALIZATION DOGMA IS OUR BEST TOOL IN DISAMBIGUATING RESEARCH FINDINGS

    May 1, 2019, 00:00

  • PMU53 ASSESSMENT OF THE ROUTES OF PATIENTS IN HUNGARIAN ONE-DAY SURGERY

    May 1, 2019, 00:00

  • PCV87 CHARACTERISTICS OF ATRIAL FIBRILLATION PATIENTS TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS AND HAVING UNDERGONE CARDIOVERSION

    May 1, 2019, 00:00

  • Drugs Information Systems

    May 1, 2019, 00:00

  • PCV64 PRIOR USE OF MEDICATION FOR PRIMARY PREVENTION IN PATIENTS WITH CORONARY SYNDROME

    May 1, 2019, 00:00

  • PNS227 STRESS AND ITS ASSOCIATION WITH ADVANCED PHARMACY PRACTICE EXPERIENCES AMONG PHARMACY STUDENTS

    May 1, 2019, 00:00

  • PMU13 WHY IS QUALITATIVE EVIDENCE SYNTHESIS OVERLOOKED AND UNDERVALUED?

    May 1, 2019, 00:00

  • PNS114 BUNDLED PAYMENTS FOR CARE IMPROVEMENT ADVANCED (BPCI-A): AN ANALYSIS OF PUBLIC COMMUNICATIONS DURING THE APPLICATION PERIOD

    May 1, 2019, 00:00

  • PCV11 COMPARATIVE EFFECTIVENESS OF FONDAPARINUX AND ENOXAPARIN AMONG PATIENTS ADMITTED TO INTENSIVE CARE: ANALYSIS OF ELECTRONIC HEALTH RECORD DATA

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Health Policy Regulatory

    May 1, 2019, 00:00

  • Drugs Generics - Clinical Outcomes

    May 1, 2019, 00:00

  • PCN278 REAL WORLD TREATMENT PATTERNS FOR FIRST LINE (1L) RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) PATIENTS

    May 1, 2019, 00:00

  • PCV14 AN APPRAISAL OF REAL-WORLD EVIDENCE (RWE) IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (NVAF) TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS (NOACS)

    May 1, 2019, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Health Policy Regulatory

    May 1, 2019, 00:00

  • Medical Devices - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PCV20 LIMITATIONS OF ENTERIC-COATED ASPIRIN UNDERSCORE THE NEED FOR A NEXT GENERATION, SAFER AND EFFECTIVE ASPIRIN OPTION

    May 1, 2019, 00:00

  • PIN59 BURDEN OF DISEASE OF HEALTHCARE-ASSOCIATED INFECTIONS IN ARGENTINA

    May 1, 2019, 00:00

  • PIN74 IMPACT OF HEALTHCARE UTILIZATION ON MENINGOCOCCAL ADOLESCENT VACCINATION IN THE UNITED STATES (US)

    May 1, 2019, 00:00

  • PMU11 A COMPARISON BETWEEN ICER AND NICE COST-EFFECTIVENESS MODELS

    May 1, 2019, 00:00

  • PIN43 THE ECONOMIC BURDEN OF ANTIMICROBIAL RESISTANCE: RESULTS FROM A TARGETED LITERATURE REVIEW

    May 1, 2019, 00:00

  • PDB117 A NEW MODEL OF INTEGRATED CARE FOR COMPLEX TYPE 2 DIABETES IN UNDERSERVED POPULATIONS: A STUDY PROTOCOL FOR A COST-EFFECTIEVENESS ANALYSIS

    May 1, 2019, 00:00

  • PCV111 SAFETY PROFILE OF AMIODARONE AND DRONEDARONE: A PHARMACOEPIDEMIOLOGIC ANALYSIS USING FDA ADVERSE EVENTS REPORTING SYSTEM (FAERS) DATABASE.

    May 1, 2019, 00:00

  • PNS77 ARTIFICIAL INTELLIGENCE IN MEDICAL DEVICES: REGULATORY AND REIMBURSEMENT LANDSCAPE IN THE UNITED STATES

    May 1, 2019, 00:00

  • PIN2 BACTERIAL INFECTIONS CAUSED BY INTRAVENOUS SUPPLIES

    May 1, 2019, 00:00

  • PND7 A LONGITUDINAL EXAMINATION OF PROGRESSION-RELATED EVENTS AMONG MEDICARE BENEFICIARIES WITH AND WITHOUT PARKINSON'S DISEASE

    May 1, 2019, 00:00

  • PIN57 PREVALENCE OF MEDICARE BENEFICIARIES WITH A RECENT DIAGNOSIS OF CHRONIC HEPATITIS C IN 2016

    May 1, 2019, 00:00

  • Mental Health - Health Policy Regulatory

    May 1, 2019, 00:00

  • PDG48 POTENTIALLY INAPPROPRIATE PRESCRIPTIONS OF ANTICHOLINERGIC MEDICATIONS IN PATIENTS WITH CLOSED-ANGLE GLAUCOMA

    May 1, 2019, 00:00

  • PIN4 VIROLOGIC OUTCOMES AMONG TREATMENT NAIVE HIV+ PATIENTS INITIATING COMMON FIRST ANTIRETROVIRAL THERAPY CORE AGENTS IN THE OPERA OBSERVATIONAL DATABASE

    May 1, 2019, 00:00

  • PNS165 TRENDS IN THE UPTAKE AND IMPACT OF THE INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW (ICER) VALUE ASSESSMENT FRAMEWORK (VAF) IN COVERAGE DECISIONS

    May 1, 2019, 00:00

  • PDB2 COMPARATIVE EFFICACY AND SAFETY OF PHARMACOTHERAPIES FOR THE TREATMENT OF OBESITY AMONG ADULTS: A SYSTEMATLIC LITERATURE AND NETWORK META-ANALYSIS

    May 1, 2019, 00:00

  • PMH24 HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH MENTAL HEALTH IN PATIENTS WITH OPIOID USE DISORDERS

    May 1, 2019, 00:00

  • PMU88 USING MACHINE LEARNING FOR PHENOTYPIC PREDICTION TO EXPLORE COMPLEX CODING PATTERNS IN REAL-WORLD HEALTHCARE DATABASES: AN APPLICATION TO SURGICAL CONVERSION

    May 1, 2019, 00:00

  • PMH41 IMPACT OF GEOGRAPHIC ACCESS TO PROVIDERS ON TREATMENT ENGAGEMENT AND COMPLETION IN PEDIATRIC DEPRESSION POPULATION IN SOUTHEAST TEXAS

    May 1, 2019, 00:00

  • PPM5 TIMING AND THE COST-EFFECTIVENESS OF POPULATION-WIDE GENOMIC SCREENING FOR BREAST AND OVARIAN CANCER

    May 1, 2019, 00:00

  • PMH19 COST-EFFECTIVENESS ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS187 US NATIONAL TRENDS OF MOBILE HEALTH APPS USE IN 2014 AND 2018

    May 1, 2019, 00:00

  • PND46 PREDICTORS OF DELIRIUM AMONG CARDIOVASCULAR SURGICAL INTENSIVE CARE UNIT PATIENTS AT DEBAKEY HEART CENTER

    May 1, 2019, 00:00

  • PNS199 PREDICTING FALLS IN ELDERLY PATIENTS USING CLAIMS DATA: A TIME-AWARE DEEP LEARNING APPROACH

    May 1, 2019, 00:00

  • PH4 ASSOCIATION BETWEEN POLYPHARMACY AND HEALTH-RELATED QUALITY OF LIFE AMONG CANCER SURVIVORS IN THE UNITED STATES

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Real World Data Information Systems

    May 1, 2019, 00:00

  • PCN242 APPROACHES TO PRAGMATIC METHODOLOGY IN ONCOLOGY RETROSPECTIVE STUDIES

    May 1, 2019, 00:00

  • Gastrointestinal Disorders - Epidemiology Public Health

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Methodological Statistical Research

    May 1, 2019, 00:00

  • PND80 RAPID MIGRAINE RESPONSE BY MONTH 1 AND CLINICALLY MEANINGFUL IMPROVEMENTS IN HEALTH RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH MIGRAINE IN PHASE 3 TRIALS OF EPTINEZUMAB

    May 1, 2019, 00:00

  • PNS219 A NOVEL METHOD FOR ASSESSING FEASIBILITY OF GENERATING REAL-WORLD DATA BASED CONTROL GROUPS

    May 1, 2019, 00:00

  • PIT12 COST OF PARAQUAT POISONING IN COLOMBIA

    May 1, 2019, 00:00

  • PNS75 THE QUALITY OF CARE WORKERS IN LONG-TERM CARE INSTITUTIONS IN ZHEJIANG PROVINCE, CHINA

    May 1, 2019, 00:00

  • Adherence, Persistence and Compliance Studies

    May 1, 2019, 00:00

  • PNS170 NICE END OF LIFE - SURVIVAL CRITERION: STRICT IMPLEMENTATION OR PRAGMATIC FLEXIBILITY?

    May 1, 2019, 00:00

  • PMD6 THE ACIST I CVI® VARIABLE RATE CONTRAST DELIVERY SYSTEM REDUCES COSTS OF CORONARY CATHETERIZATIONS COMPARED WITH MANUAL INJECTION

    May 1, 2019, 00:00

  • PNS60 CULTURAL AND SOCIAL FACTORS AFFECTING CIGARETTE SMOKING HABITS AMONG YOUNG EDUCATED PEOPLE IN KURDISTAN REGION / IRAQ

    May 1, 2019, 00:00

  • PMD36 REDUCTION IN PEDICLE SCREW PLACEMENT TIME WITH A NOVEL GUIDEWIRELESS PEDICLE SCREW SYSTEM FOR MINIMALLY INVASIVE SPINE SURGERY: INITIAL FINDINGS

    May 1, 2019, 00:00

  • PMD25 FACTORS INFLUENCING PHYSICIAN'S PRESCRIPTION AND REIMBURSEMENT OF MEDICAL DEVICES USED IN LARYNGECTOMY REHABILITATION IN EUROPE

    May 1, 2019, 00:00

  • PDB90 FEASIBILITY OF A MULTI-COMPONENT DIABETES MANAGEMENT INTERVENTION BY PHARMACISTS: COORDINATION WITHIN A COMMUNITY PHARMACY NETWORK

    May 1, 2019, 00:00

  • PIN93 PREDICTION MODEL OF TREATMENT FAILURE AMONG CHRONIC HEPATITIS C PATIENTS AT FOUR UNITED STATES INSTITUTIONS

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Real World Data Information Systems

    May 1, 2019, 00:00

  • PND52 PATTERNS OF UTILIZATION OF DRUGS FOR MIGRAINE IN A COLOMBIAN POPULATION

    May 1, 2019, 00:00

  • PDG73 TRENDS, PATIENT AND PRESCRIBER CHARACTERISTICS AND OFF-LABEL USE OF GABAPENTINOIDS AMONG UNITE STATES AMBULATORY CARE VISITS FROM 2003-2015

    May 1, 2019, 00:00

  • Cancer - Patient-Centered Research

    May 1, 2019, 00:00

  • PCV103 A CLOSER LOOK AT MEDICATION ADHERENCE AND THE ROLE OF IMPROVED BEHAVIORS AND DEPRESSION

    May 1, 2019, 00:00

  • PDB14 REAL WORLD INFLUENCING FACTORS OF GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND GLYCEMIC PREDICT MODELS BASED ON MAIN INFLUENCING FACTORS

    May 1, 2019, 00:00

  • PDG8 EFFICACY OF PHARMACOLOGICAL MONOTHERAPIES FOR TYPE 2 DIABETES IN CHINA

    May 1, 2019, 00:00

  • PNS11 PATIENT-CENTERED METHODS: CONSIDERATIONS FOR QUALITATIVE RESEARCH TO SUPPORT CONTENT VALIDITY WHEN DEVELOPING CLINICAL OUTCOME ASSESSMENT (COA) MEASURES APPROPRIATE FOR ADOLESCENT PATIENTS (AGED 12-17 YEARS OLD)

    May 1, 2019, 00:00

  • PMD39 MEASURING HEALTH-RELATED QUALITY OF LIFE IN INDIVIDUALS WITH SICKLE CELL DISEASE UNDERGOING AUTOMATED RED BLOOD CELL EXCHANGE

    May 1, 2019, 00:00

  • PDB17 INDIRECT TREATMENT COMPARISON OF SGLT2 INHIBITOR MONOTHERAPY IN PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES ON DIET/EXERCISE OR METFORMIN

    May 1, 2019, 00:00

  • PNS79 IMPACT OF INTERNATIONAL REFERENCE PRICING ON FIVE PRODUCTS IN THE USA

    May 1, 2019, 00:00

  • PNS138 EVALUATION OF COLLABORATIONS AND PARTNERSHIPS ACROSS HEALTHCARE INDUSTRY SEGMENTS TO DRIVE TRIPLE AIM GOALS

    May 1, 2019, 00:00

  • PCV107 PREFERENCE AND WILLINGNESS-TO-PAY FOR NOVEL ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – PRELIMINARY RESULTS FROM A TWO-CENTRE SURVEY IN CHINA

    May 1, 2019, 00:00

  • PMU61 VARIABLE BIOSIMILAR COVERAGE ACROSS US COMMERCIAL PLANS

    May 1, 2019, 00:00

  • Combining Health and Outcomes Beyond Health in Complex Evaluations of Complex Interventions: Suggestions for Economic Evaluation

    May 1, 2019, 00:00

  • PDG38 PREVIOUSLY UNKNOWN RISK OF PERIPHERAL NEUROPATHY WITH CEFOXITIN AND AMIKACIN

    May 1, 2019, 00:00

  • PGI15 ONE-YEAR RESOURCE USE FOR MEDICATION-REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE PATIENTS TREATED WITH LAPAROSCOPIC NISSEN FUNDOPLICATION OR LINX REFLUX MANAGEMENT SYSTEM: A SURVEY OF 99 U.S. CLINICIANS

    May 1, 2019, 00:00

  • PIN21 COST-EFFECTIVENESS ANALYSIS OF TAFENOQUINE WITH A RAPID DIAGNOSTIC TEST FOR G6PD DEFICIENCY IN PATIENTS WITH PLASMODIUM VIVAX INFECTIONS IN BRAZIL

    May 1, 2019, 00:00

  • Mental Health - Patient-Centered Research

    May 1, 2019, 00:00

  • PMU41 ASSOCIATION BETWEEN POLYPHARMACY AND HEALTH-RELATED QUALITY OF LIFE AMONG US ADULTS WITH CARDIOMETABOLIC RISK FACTORS: A POPULATION-LEVEL ANALYSIS

    May 1, 2019, 00:00

  • PIN5 REAL WORLD EXPERIENCE WITH DOLUTEGRAVIR-BASED TWO-DRUG REGIMENS

    May 1, 2019, 00:00

  • Medical Devices - Patient-Centered Research

    May 1, 2019, 00:00

  • PNS196 USE OF MACHINE LEARNING IN HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR): OPTIMIZING PREDICTIVE MODELS

    May 1, 2019, 00:00

  • PMD12 HEALTH ECONOMIC IMPACT OF THE TECHNOLOGY “OSTEOSYNTHESIS” ON FRACTURE CARE: AN ECONOMIC ANALYSIS FOR 17 HIGH INCOME COUNTRIES OVER THE COURSE OF 60 YEARS

    May 1, 2019, 00:00

  • PND2 TRANSITIONS ACROSS COGNITIVE STATES WITH OR WITHOUT THE USE OF FDA-APPROVED MEDICATIONS FOR ALZHEIMER'S DISEASE

    May 1, 2019, 00:00

  • PDG7 WEIGHT LOSS AND SAFETY OF FOUR APPETITE SUPPRESSANTS DRUG: A META-ANALYSIS

    May 1, 2019, 00:00

  • PMU104 EXPLAINING DIFFERENCES IN HEALTH-RELATED QUALITY OF LIFE (HRQOL) BETWEEN PERSISTENT AND NON-OPIOID USERS WITH CHRONIC NON-CANCER PAIN CONDITIONS (CNCP): A POST-REGRESSION DECOMPOSITION ANALYSIS.

    May 1, 2019, 00:00

  • PDG25 COST-EFFECTIVENESS OF ONCE WEEKLY DULAGLUTIDE 1.5 MG VERSUS ONCE DAILY LIRAGLUTIDE 1.8 MG FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN CHINA

    May 1, 2019, 00:00

  • PIH16 ECONOMIC AND CLINICAL OUTCOMES AMONG WOMEN WITH ABNORMAL UTERINE BLEEDING TREATED WITH INPATIENT OR OUTPATIENT HYSTERECTOMY VERSUS ENDOMETRIAL ABLATION

    May 1, 2019, 00:00

  • PIH32 ANNUAL HEALTH INSURANCE TREATMENT COST OF ENDOMETRIOSIS IN HUNGARY: A NATIONWIDE COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    May 1, 2019, 00:00

  • PIH27 THE CASE FOR THE INCLUSION OF HUMAN MILK INTO GEORGIA STATE'S MEDICAID REIMBURSEMENT STRUCTURE: A BUDGET IMPACT ANALYSIS

    May 1, 2019, 00:00

  • Neurological Disorders - Medical Technologies

    May 1, 2019, 00:00

  • PMU101 MOST BOTHERSOME SYMPTOM MEASUREMENT STRATEGIES: CONSIDERATIONS FOR REGULATED CLINICAL TRIALS

    May 1, 2019, 00:00

  • PMS41 CHANGES OVER TIME IN TREATMENT AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN JAPAN: EVIDENCE FROM JMDC INC. DATABASE

    May 1, 2019, 00:00

  • PMU57 A REMEDY FOR DESPAIR? SHORT-TERM CHANGES IN ECONOMIC CONDITIONS AND OPIOID PRESCRIBING IN WASHINTON STATE

    May 1, 2019, 00:00

  • PDB22 ANTIHYPERGLYCEMIC TREATMENT REGIMENS BEFORE AND AFTER A SKILLED NURSING FACILITY STAY AMONG PATIENTS WITH TYPE 2 DIABETES

    May 1, 2019, 00:00

  • PNS129 PRIVATE PAYER PERSPECTIVES ON THE BENEFITS OF FEDERAL ANTI-KICKBACK STATUTE MODERNIZATION TO PROMOTE VALUE-BASED ARRANGEMENTS FOR MEDICINES

    May 1, 2019, 00:00

  • PIH36 ECONOMIC BURDEN OF UNINTENDED PREGNANCY IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCV37 REIMBURSEMENT OF AMBULATORY BLOOD PRESSURE MONITORING IN THE COMMERCIAL INSURANCE MARKETPLACE

    May 1, 2019, 00:00

  • PMD18 A COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA IN FRANCE

    May 1, 2019, 00:00

  • PMS6 ANALYSIS OF A JUMP-LANDING TASK BETWEEN INJURED AND UNINJURED ADOLESCENT BASKETBALL PLAYERS

    May 1, 2019, 00:00

  • PIN23 COST-EFFECTIVENESS EVALUATION OF ARTIFICIAL INTELLIGENCE MONITORING OF ACTIVE TUBERCULOSIS TREATMENT IN LOS ANGELES COUNTY, CALIFORNIA: A PILOT STUDY

    May 1, 2019, 00:00

  • PCN257 USE OF AUC IN ONCOLOGY SURVIVAL CURVE TO ASSESS COST IN MEA NEGOATION

    May 1, 2019, 00:00

  • PMH36 NON-SELECTIVE ANTIMUSCARINIC MEDICATION USE AMONG ELDERLY DEMENTIA PATIENTS WITH OVERACTIVE BLADDER

    May 1, 2019, 00:00

  • PNS195 MODELLING HETEROGENEOUS PUBLIC PREFERENCES IN DISCRETE CHOICE EXPERIMENTS: AN APPLICATION TO PRENATAL SCREENING AND DIAGNOSTIC STRATEGIES FOR CHROMOSOMAL ABNORMALITIES

    May 1, 2019, 00:00

  • PNS197 TWO APPROACHES TO EVALUATE MISSING CLINICAL OUTCOME ASSESSMENT RESPONSES: A SIMULATION STUDY

    May 1, 2019, 00:00

  • PNS222 IMPUTATION TECHNIQUES FOR MISSING COVARIATES WHEN MODELING DISEASE PROGRESSION

    May 1, 2019, 00:00

  • PMD4 RETROSPECTIVE ANALYSIS OF OXIDIZED ZIRCONIUM BEARING SURFACE IN HIP AND KNEE REPLACEMENT 90-DAY EPISODE CLAIMS

    May 1, 2019, 00:00

  • PGI6 ECONOMIC BURDEN OF PROGRESSION TO CIRRHOSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCV91 FACTORS ASSOCIATED WITH AVOIDING HEALTHCARE AMONG ADULTS WITH HYPERTENSION: AN ANALYSIS OF THE 2015 MEDICARE CURRENT BENEFICIARY SURVEY

    May 1, 2019, 00:00

  • PDB71 VALIDITY AND RELIABILITY OF HINT-8 IN PATIENTS WITH DIABETES MELLITUS

    May 1, 2019, 00:00

  • PNS64 HEALTH-RELATED QUALITY OF LIFE INEQUALITIES BY GENDER IDENTITY AND SEXUAL ORIENTATION AND ROLE OF DEPRESSION AS AN EXPLANATORY VARIABLE

    May 1, 2019, 00:00

  • PDG57 THE IMPACT OF GENERIC MARKET EXCLUSIVITY BY THE PATENT-REGISTRATION LINKAGE SYSTEM IN KOREA

    May 1, 2019, 00:00

  • PMH30 UNDERSTANDING TRENDS IN DEMENTIA AND COGNITIVE IMPAIRMENT IN THE UNITED STATES: EVIDENCE FROM THE HEALTH AND RETIREMENT STUDY (HRS)

    May 1, 2019, 00:00

  • PMU66 EXAMINING THE RELATIONSHIP BETWEEN PATIENT SATISFACTION AND ANTIBIOTIC PRESCRIBING FOR ACUTE ADULT BRONCHITIS IN AN AMBULATORY SETTING

    May 1, 2019, 00:00

  • PDG62 CURRENT TREATMENT STATUS WITH PROPROTEIN CONVERTASE SUBTILISIN-KEXIN TYPE 9 INHIBITORS IN PATIENTS BASED ON A REAL-WORLD DATA ANALYSIS IN USA

    May 1, 2019, 00:00

  • Personalized Precision Medicine - Health Technology Assessment

    May 1, 2019, 00:00

  • PDB60 COST-EFFECTIVENESS OF LIXISENATIDE COMBINED WITH BASAL INSULIN VERSUS INSULIN REGIMENS FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY BASAL INSULIN IN CHINA

    May 1, 2019, 00:00

  • PIN37 COST-EFFECTIVENESS ANALYSIS OF FIDAXOMICIN FOR CLOSTRIDIUM DIFFICILE INFECTION IN JAPAN

    May 1, 2019, 00:00

  • PND48 ADHERENCE TO MIGRAINE PROPHYLACTICS IS ASSOCIATED WITH IMPROVED HEALTH RESOURCE UTILIZATION

    May 1, 2019, 00:00

  • PCV42 MYOCARDIAL INFARCTION: ECONOMIC, HEALTH, AND SOCIAL IMPACTS ON INFORMAL CAREGIVERS

    May 1, 2019, 00:00

  • PND66 EVALUATION OF AN INTERPROFESSIONAL TELEHEALTH PROGRAM FOR PATIENTS WITH EPILEPSY

    May 1, 2019, 00:00

  • PIN89 COST-EFFECTIVENESS ANALYSIS OF PNEUMOCOCCAL CONJUGATE VACCINES IN CHILDREN IN A DINAMIC COHORT IN COLOMBIA, 2018-2027

    May 1, 2019, 00:00

  • PIT21 EXPLORING COST OF AND TREATMENT PATTERNS WITH AUTOGRAFT DURING HOSPITALIZATIONS FOR THERMAL BURN PATIENTS IN A COMMERCIALLY INSURED POPULATION

    May 1, 2019, 00:00

  • PIN84 THE ROLE OF COMORBIDITIES, INFECTIONS, AND TREATMENTS IN SEPSIS: A RETROSPECTIVE ANALYSIS OF A LARGE US ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • PMU73 HOSPITAL INPATIENT OUTCOME OF HEPATITIS C PATIENTS CO-INFECTED WITH HIV IN THE UNITED STATES: RESULTS FROM 2014 NATIONAL INPATIENT SAMPLE

    May 1, 2019, 00:00

  • PMH46 WHAT IS THE EFFECTIVENESS OF INCLUDING PHARMACISTS IN COLLABORATIVE CARE PROGRAMS FOR MENTAL HEALTH TREATMENT? A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PIH22 TIME COSTS OF ADMINISTERING CHLAMYDIA SCREENING TO AFRICAN AMERICAN MEN IN NON-CLINICAL SETTINGS

    May 1, 2019, 00:00

  • PNS220 CHARACTERISTICS AND METHODS OF INCORPORATING RANDOMIZED AND NON-RANDOMIZED EVIDENCE IN NETWORK META-ANALYSES: A SCOPING REVIEW

    May 1, 2019, 00:00

  • PCN308 REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON–SMALL CELL LUNG CANCER (NSCLC)

    May 1, 2019, 00:00

  • PCN314 REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH METASTATIC RENAL CELL CARCINOMA RECEIVING FIRST-LINE THERAPY IN THE UNITED STATES VETERAN POPULATION

    May 1, 2019, 00:00

  • Drugs Generics - Economic Evaluation

    May 1, 2019, 00:00

  • PNS23 CONSIDERATIONS FOR UPDATING EXISTING LINGUISTICALLY VALIDATED CLINICAL OUTCOME ASSESSMENTS (COAS)

    May 1, 2019, 00:00

  • Multiple Diseases - Health Technology Assessment

    May 1, 2019, 00:00

  • Editorial Board

    Apr 9, 2019, 09:28

  • Perspectives of Patients With Cancer on the Quality-Adjusted Life Year as a Measure of Value in Healthcare

    Apr 1, 2019, 00:00

  • Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis

    Apr 1, 2019, 00:00

  • Bayesian Networks for Risk Prediction Using Real-World Data: A Tool for Precision Medicine [Editor's Choice]

    Apr 1, 2019, 00:00

  • Eliciting Health State Utilities Using Paired-Gamble Methods: The Role of the Starting Point

    Apr 1, 2019, 00:00

  • Patient-Centered Item Selection for a New Preference-Based Generic Health Status Instrument: CS-Base

    Apr 1, 2019, 00:00

  • Adoption of New Medical Technologies: The Case of Customized Individually Made Knee Implants

    Apr 1, 2019, 00:00

  • Conditional Financing of Drugs in the Netherlands: Past, Present, and Future—Results From Stakeholder Interviews

    Apr 1, 2019, 00:00

  • Measuring Survival Benefit in Health Technology Assessment in the Presence of Nonproportional Hazards

    Apr 1, 2019, 00:00

  • Copyright/Subscription

    Apr 1, 2019, 00:00

  • Estimating Joint Health Condition Utility Values [Editor's Choice]

    Apr 1, 2019, 00:00

  • To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in Ireland

    Apr 1, 2019, 00:00

  • Understanding Patients' Preferences: A Systematic Review of Psychological Instruments Used in Patients' Preference and Decision Studies [Editor's Choice]

    Apr 1, 2019, 00:00

  • Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model

    Apr 1, 2019, 00:00

  • Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States

    Apr 1, 2019, 00:00

  • A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis [Editor's Choice]

    Apr 1, 2019, 00:00

  • Table of Contents

    Apr 1, 2019, 00:00

  • Correction

    Apr 1, 2019, 00:00

  • Editorial Board

    Mar 18, 2019, 18:11

  • Editorial Board

    Mar 13, 2019, 10:06

  • Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine

    Mar 1, 2019, 00:00

  • Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report

    Mar 1, 2019, 00:00

  • Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data [Editor's Choice]

    Mar 1, 2019, 00:00

  • Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018

    Mar 1, 2019, 00:00

  • Valuation of Health States Considered to Be Worse Than Death—An Analysis of Composite Time Trade-Off Data From 5 EQ-5D-5L Valuation Studies

    Mar 1, 2019, 00:00

  • Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups [Editor's Choice]

    Mar 1, 2019, 00:00

  • Copyright/Subscription

    Mar 1, 2019, 00:00

  • Table of Contents

    Mar 1, 2019, 00:00

  • Comparative Effectiveness of Computed Tomography Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma [Editor's Choice]

    Mar 1, 2019, 00:00

  • Measuring Weight-Specific Quality of Life in Adolescents: An Examination of the Concurrent Validity and Test-Retest Reliability of the WAItE

    Mar 1, 2019, 00:00

  • Evaluating Canadians’ Values for Drug Coverage Decision Making

    Mar 1, 2019, 00:00

  • Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study

    Mar 1, 2019, 00:00

  • Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions

    Mar 1, 2019, 00:00

  • Challenges with Forecasting Budget Impact: A Case Study of Six ICER Reports

    Mar 1, 2019, 00:00

  • Correction

    Mar 1, 2019, 00:00

  • Use of Both Qualitative and Quantitative Methods to Estimate Meaningful Change Thresholds for Key Endpoints in Pediatric Asthma Trials

    Mar 1, 2019, 00:00

  • Choice of Prosthetic Implant Combinations in Total Hip Replacement: Cost-Effectiveness Analysis Using UK and Swedish Hip Joint Registries Data

    Mar 1, 2019, 00:00

  • Editorial Board

    Feb 1, 2019, 10:11

  • Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease

    Feb 1, 2019, 00:00

  • The Cost-Effectiveness of Financial Incentives for Viral Suppression- HPTN 065 Study

    Feb 1, 2019, 00:00

  • The Internal Validity of Discrete Choice Experiment Data- A Testing Tool for Quantitative Assessments [Editor's Choice]

    Feb 1, 2019, 00:00

  • Association between Disability, Cognition, Fatigue, EQ-5D-3L Domains, and Utilities Estimated with Different Western European Value Sets in Patients with Multiple Sclerosis

    Feb 1, 2019, 00:00

  • Table of Contents

    Feb 1, 2019, 00:00

  • Copyright/Subscription

    Feb 1, 2019, 00:00

  • Estimating CHU-9D Utility Scores from the WAItE- A Mapping Algorithm for Economic Evaluation

    Feb 1, 2019, 00:00

  • Economic Evaluation of Stem Cell Therapies in Neurological Diseases- A Systematic Review

    Feb 1, 2019, 00:00

  • Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women

    Feb 1, 2019, 00:00

  • Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States

    Feb 1, 2019, 00:00

  • Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs [Editor's Choice]

    Feb 1, 2019, 00:00

  • A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)

    Feb 1, 2019, 00:00

  • Methods for Measuring Multiple Medication Adherence- A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group

    Feb 1, 2019, 00:00

  • Equity Weights for Socioeconomic Position- Two Methods—Survey of Stated Preferences and Epidemiological Data

    Feb 1, 2019, 00:00

  • Perceptions of Response Burden Associated with Completion of Patient-Reported Outcome Assessments in Oncology [Editor's Choice]

    Feb 1, 2019, 00:00

  • Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke

    Feb 1, 2019, 00:00

  • Comparison of Recommendations and Use of Cardiovascular Risk Equations by Health Technology Assessment Agencies and Clinical Guidelines

    Feb 1, 2019, 00:00

  • Response to letter to the editor related to the retraction of a trial included in a meta-analysis of interventions to enhance oral medication adherence titled “Effectiveness and content analysis of interventions to enhance oral antidiabetic ...

    Feb 1, 2019, 00:00

  • The Retraction of a Trial Included in a Meta-Analysis of Interventions to Enhance Oral Medication Adherence

    Feb 1, 2019, 00:00

  • Market Consolidation and Mortality in Patients Initiating Hemodialysis

    Jan 1, 2019, 00:00

  • Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice

    Jan 1, 2019, 00:00

  • Instructions for Authors

    Jan 1, 2019, 00:00

  • The EQ-5D and the EuroQol Group

    Jan 1, 2019, 00:00

  • Identifying Patients With Relapsing-Remitting Multiple Sclerosis Using Algorithms Applied to US Integrated Delivery Network Healthcare Data

    Jan 1, 2019, 00:00

  • Table of Contents

    Jan 1, 2019, 00:00

  • EQ-5D-Y as a Health-Related Quality of Life Instrument for Children and Adolescents: The Instrument's Characteristics, Development, Current Use, and Challenges of Developing Its Value Set

    Jan 1, 2019, 00:00

  • Pediatric Quality of Life Instruments in Oral Health Research: A Systematic Review

    Jan 1, 2019, 00:00

  • Correspondence

    Jan 1, 2019, 00:00

  • Future Directions in Valuing Benefits for Estimating QALYs: Is Time Up for the EQ-5D?

    Jan 1, 2019, 00:00

  • Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?

    Jan 1, 2019, 00:00

  • Physical Activity and Risk of Breast Cancer: A Meta-Analysis of 38 Cohort Studies in 45 Study Reports

    Jan 1, 2019, 00:00

  • Medical Nutrition Terminology and Regulations in the United States and Europe—A Scoping Review: Report of the ISPOR Nutrition Economics Special Interest Group

    Jan 1, 2019, 00:00

  • Copyright/Subscription

    Jan 1, 2019, 00:00

  • Assessing Emotional Functioning with Increased Power: Relative Validity of a Customized EORTC Short Form in the International ACTION Trial

    Jan 1, 2019, 00:00

  • Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA [Editor's Choice]

    Jan 1, 2019, 00:00

  • Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter? [Editor's Choice]

    Jan 1, 2019, 00:00

  • Selecting Bolt-On Dimensions for the EQ-5D: Examining Their Contribution to Health-Related Quality of Life

    Jan 1, 2019, 00:00

  • Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol [Editor's Choice]

    Jan 1, 2019, 00:00

  • Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common Comparator

    Jan 1, 2019, 00:00

  • Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping

    Dec 1, 2018, 00:00
  • «
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49 (current)
  • 50
  • »